Special measures have been passed in Australia which exempt specified treatments for COVID-19 from requirements to be registered on the Australian Register of Therapeutic Goods (ARTG) prior to their supply.

Mobile drug testing (MDT) is a method used to detect drugs at a traffic stop or at a random breath testing (RBT) site.

Australians can no longer purchase over-the-counter (OTC) medications containing codeine.

The doctor had acted carelessly, incompetently and improperly, in a way that constituted professional misconduct.

Businesses must provide greater transparency and the country of origin of their packaged food, or face large penalties.

Australian consumer affairs ministers agreed to replace existing mandatory Country-of-Origin food labelling requirements.

The Code (as presently drafted) would only apply to retailers who have voluntarily agreed in writing to be bound by it.

The aged care provider remedied deficiencies in the medication management system that was exploited by a former employee.

Compulsory patent licensing laws are being amended to support export of patented pharmaceuticals to countries in need.

The TRIPS Agreement sets out the minimum requirements for intellectual property protection for WTO member states.

Making an application for listing of a patented pharmaceutical product on the PBS would not infringe the patent.

This recent decision highlights the importance of including Swiss-style claims in Australian pharmaceutical patents.

This section considered the possibility of increasing food production while still meeting renewable energy targets.

An employee who smoked cannabis before work was not unfairly dismissed for breach of the employer's zero tolerance policy.

The Food Safety Modernization Act (FSMA) is the US Food and Drug Administration's most sweeping reform in over 70 years.

The COVID-19 vaccination compensation scheme offers welcome reassurance for patients, but questions remain.

The level of care available to the patient may have been less than that regarded as adequate for patients not in custody.

This case set a new benchmark in Australia for future patent infringement damages claims against generic manufacturers.

The application for PBS listing was not an 'offer to supply' within the definition of 'exploit' in the Patents Act.

This article identifies impacts and opportunities and emerging markets in the global food and agribusiness industry.